Substantial evidence suggests that the mTOR signaling pathway is not only closely associated with the proliferation and differentiation of tumor cells but also plays a crucial role in the maintenance of cancer stem cells, potentially contributing to drug resistance in RCC.48, 49. Here, MTOR is linked to renal cell carcinoma.